IntroductionWe read with interest an editorial by Millar1 concerning the role of hydroxychloroquine in the treatment of COVID-19 patients. Community standard of care multidrug therapies for COVID-19 were based on signals of benefit and acceptable safety.2-9 At the onset of
This is a case report of an Australian aboriginal patient from a remote region who had scabies with secondary discoid lupus erythematosus and dermatopathic lymphadenitis. Both the medical and social issues involved are discussed.
IntroductionThe editorial in the Tasman Medical Journal1 was a critique of my article in Quadrant entitled “The curious case of hydroxychloroquine”.2 It considered negative data from large clinical trials on hospitalised patients (The Recovery and Solidarity Trials), claimed scanty support from clinical studies in early COVID infection, and expressed concerns regarding the toxicity of hydroxychloroquine. Additional issues raised were the common usage of combined drug therapy in trials, and the potential need for prophylactic therapy if early treatment is beneficial.
The editor of TMJ responds to a recent article in Quadrant promoting hydroxychloroquine in early COVID-19 infection. Review of the evidence does not support the use of hydroxychloroquine in this indication.
This paper describes the development and performance of an electronic data gathering system for intra-hospital ICU “Outreach” activity, and compares it with the paper-based system it displaced.
This article is a personal case report on the treatment of type 1 diabetes.
Australia’s response to environmental PFAS contamination to minimise toxicological effects has been excellent, but several problems remain. These relate to the design of the PFAS Taskforce website and its provenance. I discuss these matters in this review.
This paper describes a novel approach to treatment of young adult patients with Borderline Personality Disorder, in which the patient has the option of determining when he or she is admitted to a specialist custom clinical psychological unit during a relapse of symptoms. Preliminary data suggests that the approach is effective in reducing symptoms and frequency of admission.
As a child the writer was told a joke about a liquid which dissolved everything. The question was what container could you keep it in?
Receive the Latest Tasman Medical Journal articles as they are published.
Subscription is free
Find out how to publish your work in the Tasman Medical Journal.
